Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Janeiro 2024 - 7:00PM
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage
biopharmaceutical company focused on the discovery, development,
and commercialization of novel treatments for patients suffering
from serious hematologic diseases, announced today that John
Quisel, J.D., PhD., President and Chief Executive Officer, will
present a company overview at the 42nd Annual J.P. Morgan
Healthcare Conference in San Francisco on Wednesday, January 10th
at 2:15 pm PT / 5:15 pm ET.
A live webcast of the presentation will be available through the
investor relations section of the Company's website at
ir.discmedicine.com and an archived replay will be available after
the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage
biopharmaceutical company committed to discovering, developing, and
commercializing novel treatments for patients who suffer from
serious hematologic diseases. We are building a portfolio of
innovative, potentially first-in-class therapeutic candidates that
aim to address a wide spectrum of hematologic diseases by targeting
fundamental biological pathways of red blood cell biology,
specifically heme biosynthesis and iron homeostasis. For more
information, please visit www.discmedicine.com.
Media Contact
Peg RusconiVerge Scientific
Communicationsprusconi@vergescientific.com
Investor Relations Contact
Christina TartagliaStern Investor
Relationschristina.tartaglia@sternir.com
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024